Crinecerfont bulk supplier for pharma manufacturers

Crinecerfont 50 mg, 100 mg, 50 mg/mL Suppliers & Bulk Manufacturers

Available Forms: Capsule / Oral solution

Available Strengths: 50 mg, 100 mg, 50 mg/mL

Reference Brands: Crenessity (USA)

Crinecerfont is used in addition to glucocorticoid replacement therapy in adults and children aged 4 years and older with classic Congenital Adrenal Hyperplasia (CAH) due to 21-hydroxylase deficiency. It works by blocking CRF1 receptors, which helps reduce the over-production of adrenocorticotropic hormone (ACTH) and subsequently lowers excess adrenal androgens. This enables better control of the disease and potentially lower steroid doses, reducing long term complications of glucocorticoid over-exposure.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Crinecerfont — third party manufacturing & bulk supply

Crinecerfont 50 mg, 100 mg, 50 mg/mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Crinecerfont is supplied as Capsule / Oral solution — supplied in more than one dosage form, each with its own manufacturing economics, so the indicative MOQ is a minimum order value of USD 5,000 per product. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Crinecerfont listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Crinecerfont →

Back to Listing

Frequently Asked Questions

Crinecerfont is listed as Capsule / Oral solution in 50 mg, 100 mg, 50 mg/mL. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Crinecerfont is referenced against Crenessity (USA). Reference brands are shown for identification only and remain the property of their respective trademark owners.